Modulators of insulin receptor activity
CA 2278023 A1 · Owner: Satyam, Apparao · Inventors: Kohanski, Ron A.; Koehler, Ryan; Spevak, Wayne R.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Methods to identify compounds from the group consisting of a composition are described. Successful substances alter the conformation of the two-lobed cytoplasmic kinase domain or preferentially bind sites which have been identified as modulator binding sites in the insulin receptor .beta. chain. Also, modulation of the activity of the insulin receptor enhancement of , glucose uptake by cells and other effects significant in the control and management of diabetes are accomplished using compounds of formula (1) wherein each Ar is independently an aromatic moiety; each A is independently a proton-accepting substituent; each R is independently a noninterfering substituent; m is 0, 1 or …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 15, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended January 15, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 15, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.